BIRC5 and neoplasm: In this subgroup, median survival time was increased to 47.3 months if the tumor was negative for both emmprin and survivin, decreased to 17.5 months if the tumor was negative for only one of the two proteins, and reduced even further to 6.6 months if the tumor was positive for both (p < 0.0001).